Link to the original source: https://onlinelibrary.wiley.com/doi/10.1002/ctm2.704
APA: Reverte, Laia; Yeregui, Elena; Olona, Montserrat; Gutierrez-Valencia, Alicia; Buzon, Maria Jose; Marti, Anna; Gomez-Bertomeu, Frederic; Auguet, Teresa (2022). Fetuin-A, inter-alpha-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Clinical And Translational Medicine, 12(1), e704-. DOI: 10.1002/ctm2.704
Paper original source: Clinical And Translational Medicine. 12 (1): e704-
Article's DOI: 10.1002/ctm2.704
Journal publication year: 2022
Entity: Universitat Rovira i Virgili
Paper version: info:eu-repo/semantics/publishedVersion
Record's date: 2025-02-19
URV's Author/s: Auguet Quintillà, Maria Teresa / Garcia Pardo, Graciano / Gomez Bertomeu, Frederic-Francesc / Martí Zaragoza, Àlex / Olona Cabases, Maria Montserrat / Peraire Forner, José Joaquin / RULL AIXA, ANNA / Vidal Marsal, Francisco / Vilades Laborda, Consuelo Gloria / Yeregui Etxeberria, Elena
Department: Medicina i Cirurgia
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Publication Type: Journal Publications
Author, as appears in the article.: Reverte, Laia; Yeregui, Elena; Olona, Montserrat; Gutierrez-Valencia, Alicia; Buzon, Maria Jose; Marti, Anna; Gomez-Bertomeu, Frederic; Auguet, Teresa; Lopez-Cortes, Luis F; Burgos, Joaquin; Benavent-Bofill, Clara; Boque, Carme; Garcia-Pardo, Graciano; Ruiz-Mateos, Ezequiel; Mestre, Maria Teresa; Vidal, Francesc; Vilades, Consuelo; Peraire, Joaquim; Rull, Anna
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Thematic Areas: Oncology, Molecular medicine, Medicine, research & experimental, Medicine (miscellaneous)
Author's mail: graciano.garcia@urv.cat, frederic-francesc.gomez@urv.cat, joaquim.peraire@urv.cat, consuelo.vilades@urv.cat, elena.yeregui@estudiants.urv.cat, alex.marti@estudiants.urv.cat, mariateresa.auguet@urv.cat, francesc.vidal@urv.cat
Repositori URV